SCHEMBL6956008

SCHEMBL6956008

CCN1c2ncc(CCc3ccccc3C)cc2C(=O)N(C)c2ccc(Cl)nc21

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.49
CYP2C9 P11712 5/20 0.49
CYP2C19 P33261 5/20 0.49
CYP1A2 P05177 3/20 0.49
CYP2D6 P10635 2/20 0.41
DAO P14920 3/20 0.34
HTR2C P28335 1/20 0.32
DCLK1 O15075 1/20 0.32
MAPK7 Q13164 1/20 0.32
LRRK2 Q5S007 1/20 0.32
TP53 P04637 1/20 0.32
NR3C2 P08235 1/20 0.31
GPR84 Q9NQS5 1/20 0.30
BRD4 O60885 1/20 0.30
KAT2B Q92831 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6963336 0.90 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6959500 0.89 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6964812 0.87 CYP3A4 (0.49) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6953361 0.86 CYP3A4 (0.50) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6965483 0.86 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6963214 0.85 CYP3A4 (0.62) CYP3A4CYP2C9CYP2C19CYP1A2DAO
SCHEMBL6958487 0.84 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL5744727 0.84 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6953985 0.84 CYP3A4 (0.42) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL6959756 0.84 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0767172-B1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 2003-03-26 EP disclosed
EP-0767172-A1 8-Arylalkyl- and 8-arylheteroalkyl-5, 11-dihydro-6H-dipyrido-[3,2-b:2', 3'-e][1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1997-04-09 EP disclosed